PM PRIORITY MEDS Trademark

Trademark Overview


On Wednesday, January 3, 2024, a trademark application was filed for PM PRIORITY MEDS with the United States Patent and Trademark Office. The USPTO has given the PM PRIORITY MEDS trademark a serial number of 98339310. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 7, 2024. This trademark is owned by Priority Meds LLC. The PM PRIORITY MEDS trademark is filed in the Advertising, Business and Retail Services category with the following description:

On-line retail store services featuring pharmaceutical preparations for the treatment of acid reflux, birth control, cold sores, hair loss, herpes, hormonal disorders, premature ejaculation, sexual and erectile dysfunction, sleep-related disorders, treatments to help stop smoking, treatments to aid with weight loss, Vitamins, and dietary and nutritional supplements
pm priority meds

General Information


Serial Number98339310
Word MarkPM PRIORITY MEDS
Filing DateWednesday, January 3, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the letters "PM" surrounded by a shield with three horizontal lines to the left of the letter "P' all in the color blue. On the inside loop of the letter "P" is the depiction of a pill half solid blue and half solid red with a void separating the colors. The words "PRIORITY MEDS" are to the right of the shield with the word "PRIORITY" in red and "MEDS" in blue. There is a solid red cross overlayed on the middle part of the letter "E" in the word "MEDS". The word and image are set on a white background.
Indication of Colors claimedThe color(s) red, white and blue is/are claimed as a feature of the mark.
Goods and ServicesOn-line retail store services featuring pharmaceutical preparations for the treatment of acid reflux, birth control, cold sores, hair loss, herpes, hormonal disorders, premature ejaculation, sexual and erectile dysfunction, sleep-related disorders, treatments to help stop smoking, treatments to aid with weight loss, Vitamins, and dietary and nutritional supplements
NOT AVAILABLE"MEDS"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 3, 2024
Primary Code035
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateWednesday, October 11, 2023

Trademark Owner History


Party NamePriority Meds LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSanta Monica, CA 90401

Trademark Events


Event DateEvent Description
Wednesday, January 3, 2024NEW APPLICATION ENTERED
Monday, March 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 22, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 30, 2024ASSIGNED TO EXAMINER
Wednesday, July 31, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 31, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 6, 2024FINAL REFUSAL E-MAILED
Tuesday, August 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 6, 2024FINAL REFUSAL WRITTEN
Thursday, November 7, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 7, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 7, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED